81 related articles for article (PubMed ID: 23002055)
1. Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients.
Girardin A; McCall J; Black MA; Edwards F; Phillips V; Taylor ES; Reeve AE; Kemp RA
Int J Cancer; 2013 Apr; 132(8):1842-50. PubMed ID: 23002055
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
3. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
Lin YC; Mahalingam J; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Chiu CT; Lin CY
Int J Cancer; 2013 Mar; 132(6):1341-50. PubMed ID: 22907255
[TBL] [Abstract][Full Text] [Related]
4. Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer.
Yang S; Wang B; Guan C; Wu B; Cai C; Wang M; Zhang B; Liu T; Yang P
J Leukoc Biol; 2011 Jan; 89(1):85-91. PubMed ID: 20952660
[TBL] [Abstract][Full Text] [Related]
5. T cell subsets and colorectal cancer: discerning the good from the bad.
Scurr M; Gallimore A; Godkin A
Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
7. An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss.
Lee SK; Kim JY; Hur SE; Kim CJ; Na BJ; Lee M; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2011 Nov; 26(11):2964-71. PubMed ID: 21926059
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of regulatory T cells (CD4+CD25+Foxp3+) correlates with tumor stage in patients with colorectal cancer.
Bacić D; Uravić M; Bacić R; Sutić I; Petrosić N
Coll Antropol; 2011 Sep; 35 Suppl 2():65-8. PubMed ID: 22220406
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
10. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping.
Brouwer-Visser J; Cheng WY; Bauer-Mehren A; Maisel D; Lechner K; Andersson E; Dudley JT; Milletti F
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):103-112. PubMed ID: 29133367
[No Abstract] [Full Text] [Related]
12. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
Gai XD; Song Y; Li C; Lei YM; Yang B
Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
[TBL] [Abstract][Full Text] [Related]
13. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients.
Deng L; Zhang H; Luan Y; Zhang J; Xing Q; Dong S; Wu X; Liu M; Wang S
Clin Cancer Res; 2010 Aug; 16(16):4105-12. PubMed ID: 20682706
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.
Wang Q; Feng M; Yu T; Liu X; Zhang P
Cell Immunol; 2014 Feb; 287(2):100-5. PubMed ID: 24487033
[TBL] [Abstract][Full Text] [Related]
16. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
17. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J
Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.
Derhovanessian E; Adams V; Hähnel K; Groeger A; Pandha H; Ward S; Pawelec G
Int J Cancer; 2009 Sep; 125(6):1372-9. PubMed ID: 19533748
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells in human autoimmune thyroid disease.
Marazuela M; García-López MA; Figueroa-Vega N; de la Fuente H; Alvarado-Sánchez B; Monsiváis-Urenda A; Sánchez-Madrid F; González-Amaro R
J Clin Endocrinol Metab; 2006 Sep; 91(9):3639-46. PubMed ID: 16804051
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer-derived Foxp3(+) IL-17(+) T cells suppress tumour-specific CD8+ T cells.
Ma C; Dong X
Scand J Immunol; 2011 Jul; 74(1):47-51. PubMed ID: 21352252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
